Constructing the prediction model for the risk of stroke in a chinese population: Report from a cohort study in Taiwan

Stroke

Volumn 41, Issue 9, 2010, Pages 1858-1864

  Chien, Kuo Liong ^a   Su, Ta Chen ^b   Hsu, Hsiu Ching ^b   Chang, Wei Tien ^b   Chen, Pei Chun ^b   Sung, Fung Chang ^c   Chen, Ming Fong ^b   Lee, Yuan Teh ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

cohort study; prediction model; stroke

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CARDIOVASCULAR RISK; CHINESE; DIASTOLIC BLOOD PRESSURE; FAMILY HISTORY; FEMALE; GERIATRICS; HEART ATRIUM FIBRILLATION; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; STATISTICS; STROKE; SYSTOLIC BLOOD PRESSURE; TAIWAN; AGE; AREA UNDER THE CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; INCIDENCE; LIFESTYLE; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; RISK; RISK ASSESSMENT; RISK FACTOR; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA;

AGE FACTORS; AGED; AREA UNDER CURVE; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; HUMANS; INCIDENCE; LIFE STYLE; MIDDLE AGED; MODELS, STATISTICAL; PROPORTIONAL HAZARDS MODELS; RISK; RISK ASSESSMENT; RISK FACTORS; STROKE; TAIWAN;

EID: 77956408746     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.586222     Document Type: Article

References (46)

1. Cholesterol, diastolic blood pressure, and stroke: 13000 strokes in 450000 people in 45 prospective cohorts. Prospective studies collaboration. Lancet. 1995;346:1647-1653.
2. Hebert PR, Gaziano JM, Chan KS, Hennekens CH. Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials. JAMA. 1997;278:313-321.
3. Davis TM, Millns H, Stratton IM, Holman RR, Turner RC. Risk factors for stroke in type 2 diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS) 29. Arch Intern Med. 1999;159:1097-1103.
4. Yang X, So WY, Kong AP, Ho CS, Lam CW, Stevens RJ, Lyu RR, Yin DD, Cockram CS, Tong PC, Wong V, Chan JC. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care. 2007; 30:65-70. (Pubitemid 46052501)
5. Almgren T, Persson B, Wilhelmsen L, Rosengren A, Andersson OK. Stroke and coronary heart disease in treated hypertension\a prospective cohort study over three decades. J Intern Med. 2005;257:496-502.
6. Park CG, Choi CU. Probability of stroke in Korean hypertensive patients visiting community-based hospitals: using a risk profile from the Fra-mingham study. J Hum Hypertens. 2009;23:252-258.
7. Wang TJ, Massaro JM, Levy D, Vasan RS, Wolf PA, D'Agostino RB, Larson MG, Kannel WB, Benjamin EJ. A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA. 2003;290:1049-1056.
8. Coca A, Redon J, Cea-Calvo L, Lozano JV, Navarro J, Fernandez-Perez C, Bonet A, Gonzalez-Esteban J. Estimated risk of a first stroke and conditioning factors in Spanish hypertensive women. The RIMH study. Blood Press. 2006;15:237-244.
9. Bestehorn K, Wahle K, Kirch W. Stroke risk screening of adults with hypertension: prospective cross-sectional study in primary care. Clin Drug Investig. 2008;28:281-289.
10. Boysen G, Nyboe J, Appleyard M, Sorensen PS, Boas J, Somnier F, Jensen G, Schnohr P. Stroke incidence and risk factors for stroke in Copenhagen, Denmark. Stroke. 1988;19:1345-1353.
11. Kammersgaard LP, Olsen TS. Cardiovascular risk factors and 5-year mortality in the Copenhagen Stroke Study. Cerebrovasc Dis. 2006;21: 187-193.
12. Lumley T, Kronmal RA, Cushman M, Manolio TA, Goldstein SA. Stroke prediction score in the elderly: validation and web-based application. J Clin Epidemiol. 2002;55:129-136.
13. Wiberg B, Sundstrom J, Arnlov J, Terent A, Vessby B, Zethelius B, Lind L. Metabolic risk factors for stroke and transient ischemic attacks in middle-aged men: a community-based study with long-term follow-up. Stroke. 2006;37:2898-2903.
14. Assmann G, Schulte H, Cullen P, Seedorf U. Assessing risk of myo-cardial infarction and stroke: new data from the Prospective Cardiovascular Munster (PROCAM) study. Eur J Clin Invest. 2007;37:925-932.
15. Chambless LE, Heiss G, Shahar E, Earp MJ, Toole J. Prediction of ischemic stroke risk in the Atherosclerosis Risk in Communities Study. Am J Epidemiol. 2004;160:259-269. (Pubitemid 39006782)
16. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke. 1991;22: 312-318.
17. Ueshima H, Sekikawa A, Miura K, Turin TC, Takashima N, Kita Y, Watanabe M, Kadota A, Okuda N, Kadowaki T, Nakamura Y, Okamura T. Cardiovascular disease and risk factors in Asia: a selected review. Circulation. 2008;118:2702-2709.
18. Chien KL, Su TC, Jeng JS, Hsu HC, Chang WT, Chen MF, Lee YT, Hu FB. Carotid artery intima-media thickness, carotid plaque and coronary heart disease and stroke in Chinese. PLoS ONE. 2008;3:e3435.
19. Chien KL, Sung FC, Hsu HC, Su TC, Lin RS, Lee YT. Apolipoprotein A1 & B, and stroke events in a community-based cohort in Taiwan: report of Chin-Shan Community Cardiovascular Study. Stroke. 2002;33:39-44.
20. Lee YT, Lin RS, Sung FC, Yang CY, Chien KL, Chen WJ, Su TC, Hsu HC, Huang YC. Chin-Shan Community Cardiovascular Cohort in Taiwan: baseline data and five-year follow-up morbidity and mortality. J Clin Epidemiol. 2000;53:836-846.
21. Chien K, Cai T, Hsu H, Su T, Chang W, Chen M, Lee Y, Hu FB. A prediction model for type 2 diabetes risk among Chinese people. Diabetologia. 2009;52: 443-450.
22. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB. Fasting and postchallenge hyperglycemia and risk of cardiovascular disease in Chinese: the Chin-Shan Community Cardiovascular Cohort study. Am Heart J. 2008;156:996-1002.
23. Chien KL, Hsu HC, Su TC, Chen MF, Lee YT, Hu FB. Apolipoprotein B and non-high-density lipoprotein cholesterol and risk of coronary heart disease in Chinese. J Lipid Res. 2007;48:2499-2505.
24. Chien KL, Hsu HC, Su TC, Lee YT. Consistency in genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples. BMC Genet. 2003; 4:7-16.
25. Chien KL, Hsu HC, Chen PC, Su TC, Chang WT, Chen MF, Lee YT. Urinary sodium and potassium excretion and risk of hypertension in Chinese: report from a community-based cohort study in Taiwan. J Hypertens. 2008;26:1750-1756.
26. Chen PC, Chien KL, Hsu HC, Su TC, Sung FC, Lee YT. Metabolic syndrome and C-reactive protein in stroke prediction: a prospective study in Taiwan. Metabolism. 2009;58:772-778.
27. Hosmer DW Jr, Lemeshow S. The Multiple Logistic Regression Model. Applied Logistic Regression, 1st ed. New York: John Wiley & Sons; 1989:25-37.
28. Lau B, Cole SR, Gange SJ. Competing risk regression models for epide-miologic data. Am J Epidemiol. 2009;170:244-256.
29. Sullivan LM, Massaro JM, D'Agostino RB Sr. Presentation of multivar-iate data for clinical use: the Framingham Study risk score functions. Stat Med. 2004;23:1631-1660.
30. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. London: Chapman & Hall/CRC; 1994.
31. Pencina MJ, D'Agostino RBS, D'Agostino RBJ, Vasan RS. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat Med. 2008;27:157-172.
32. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation. 2007;115:928-935.
33. Ridker PM, Buring JE, Rifai N, Cook NR. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score. JAMA. 2007;297:611-619.
34. Bland JM, Altman DG. Comparing methods of measurement: why plotting difference against standard method is misleading. Lancet. 1995; 346:1085-1087.
35. Martarelli D, Martarelli B, Pompei P. Body composition obtained from the body mass index: an Italian study. Eur J Nutr. 2008;47:409-416.
36. Harrell FE Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis. New York: Springer; 2001.
37. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation. 2008;117:743-753.
38. Harmsen P, Lappas G, Rosengren A, Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke. 2006;37:1663-1667.
39. NIPPON DATA80 Research Group. Risk assessment chart for death from cardiovascular disease based on a 19-year follow-up study of a Japanese representative population. Circ J. 2006;70:1249-1255.
40. Wu Y, Liu X, Li X, Li Y, Zhao L, Chen Z, Rao X, Zhou B, Detrano R, Liu K. Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults. Circulation. 2006;114:2217-2225.
41. Tanne D, Yaari S, Goldbourt U. Risk profile and prediction of long-term ischemic stroke mortality: a 21-year follow-up in the Israeli Ischemic Heart Disease (IIHD) Project. Circulation. 1998;98:1365-1371.
42. Simons LA, McCallum J, Friedlander Y, Simons J. Risk factors for ischemic stroke: Dubbo Study of the elderly. Stroke. 1998;29:1341-1346.
43. Jousilahti P, Rastenyte D, Tuomilehto J, Sarti C, Vartiainen E. Parental history of cardiovascular disease and risk of stroke. A prospective follow-up of 14 371 middle-aged men and women in Finland. Stroke. 1997;28:1361-1366.
44. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I follow-up study cohort. The Lancet. 2008;371:923-931.
45. Chien KL, Hsu HC, Su TC, Sung FC, Chen MF, Lee YT. Lipoprotein(a) and cardiovascular disease in ethnic Chinese: the Chin-Shan Community Cardiovascular Cohort Study. Clin Chem. 2008;54:285-291.
46. Altman DG, Royston P. What do we mean by validating a prognostic model? Stat Med. 2000;19:453-473.